Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICAME: sST-2 Biomarker Guided Therapy in Acute Heart Failure
NCT04554277Terminated
- Sponsor
- CHU Montpellier
- Start
- Apr 2021
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised trial in heart failure (HF) (2 arms), sponsored by CHU Montpellier. Primary endpoints: Cost-utility ratio at 2 years and Quality Adjusted Life Years at 2 years. Started Apr 2021; status: terminated.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04554277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04554277.